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ABSTRAK 
RIDING, GEORGE., SRI MUHARSINI, ROGER PEARSON, SUKARSIH, EDY SATRIA, GENE WIJFFELS, dan PETER WILLADSEN. 2000. 
Fraksinasi, identifikasi dan efikasi vaksinasi antigen natif dari lalat screwworm Chrysomya bezziana. Jurnal Ilmu Ternak dan 
Veteriner (Edisi Khusus) 5(3): 150-159. 
Beberapa protease yang diisolasi dari bahan hasil eksresi/sekresi larva dan protein membran peritrofik adalah produk 
biologik yang paling intensif dipelajari sebagai sumber antigen protektif yang potensial pada myiasis yang disebabkan oleh 
Lucilia cuprina. Peranan produk biologik sejenis sebagai antigen protektif potensial pada lalat Chrysomya bezziana sudah diteliti 
dan dilaporkan dalam tulisan ini. Protease serin yang telah dimurnikan diuji kapasitasnya sebagai antigen protektif dengan 
menyuntikkan pada domba, kemudian efekasinya sebagai vaksin dievaluasi dengan menggunakan teknik uji in vitro dan in vivo 
dengan larva lalat Chrysomya bezziana. Pada uji in vitro dengan menggunakan serum domba yang telah divaksinasi tidak 
berpengaruh terhadap pertumbuhan larva, tetapi pada uji in vivo didapatkan penurunan bobot larva pada serum domba yang 
divaksinasi walaupun jumlah larva yang ditemukan sedikit meningkat. Vaksinasi dengan membran peritrofik dari Chrysomya 
bezziana memberikan respon imunologik yang efektif terhadap parasit yang ditunjukkan dengan penurunan bobot larva dan 
peningkatan mortalitas larva secara nyata. Fraksinasi secara bertahap dari membran peritrofik dengan berbagai surfactants dan 
agen chaotrophic untuk meningkatkan daya larut berhasil memisahkan grup-grup protein yang mempunyai ciri yang berbeda-
beda. Grup-grup protein hasil fraksinasi tersebut dibuat vaksin, kemudian dicoba pada domba percobaan, untuk kemudian diuji 
efekasinya secara in vitro. Ekstrak urea, ekstrak guanidin-HCl dan fraksi yang larut di dalam SDS masing-masing merangsang 
terjadinya proteksi terhadap larva Chrysomya bezziana secara nyata, tetapi daya proteksinya masih lebih rendah dibandingkan 
dengan vaksin membran peritrofik natif yang utuh. Sebagian besar protein yang dipilih dari tiga fraksi yang paling protektif 
adalah yang dimurnikan dengan SDS polyacrylamide gel electrophoresis. Karena secara kuantitas tidak cukup banyak jumlah 
protein ini sehingga tidak mungkin digunakan untuk uji vaksin pada domba percobaan, maka protein tersebut kemudian 
disekuensi secara langsung dari terminal-amino atau didigesti dengan endoproteinase Lys-C, yang selanjutnya diikuti dengan 
pemurnian peptida dan sekuensing asam amino. Hal ini memberi informasi yang berguna untuk ekspresi beberapa di antara 
protein tersebut sebagai protein rekombinan dalam bentuk yang cocok untuk studi vaksinasi. 
Kata kunci: Chrysomya bezziana, membran peritrofik, vaksinasi, sekuensi asam amino, protease serin 
ABSTRACT 
RIDING GEORGE, SRI MUHARSINI, ROGER PEARSON, SUKARSIH, EDY SATRIA, GENE WIJFFELS and PETER WILLADSEN. 2000. 
Fractionation, identification and vaccination efficacy of native antigens from the screwworm fly, Chrysomya bezziana. Jurnal 
Ilmu Ternak dan Veteriner (Edisi Khusus) 5(3): 150-159. 
Proteases of larval excretory/secretory material and proteins of the peritrophic membrane are the most intensively studied 
sources of potential protective antigens from the sheep blowfly Lucilia cuprina. Their importance in the screwworm fly 
Chrysomya bezziana has now been investigated. Purified serine proteases from Chrysomya bezziana were tested for their 
potential as vaccine antigens in sheep, efficacy being assessed by in vitro and in vivo assays with larval Chrysomya bezziana. No 
effect of vaccination was observed by the in vitro assay. However, in the in vivo challenge, larval weights were diminished in the 
vaccinated sheep, although larval recoveries increased marginally. Vaccination with Chrysomya bezziana peritrophic membrane 
does induce an effective immune response against the parasite resulting in a significant reduction in larval growth and 
considerable larval mortality in the in vitro assay. Sequential fractionation of the peritrophic membrane with various surfactants 
and chaotrophic agents of increasing solubilisation capacity resulted in the separation of discrete groups of proteins. The groups 
of fractionated proteins were tested in a vaccination trial in sheep with vaccine efficacy assessed by in vitro assays. The urea 
extract, guanidine-HCl extract and SDS soluble fraction each induced significant levels of protection against Chrysomya 
bezziana larvae but the effects were poorer than those obtained from vaccination with whole, native peritrophic membrane. 
Several major proteins selected from the three most protective fractions were purified by SDS polyacrylamide gel 
electrophoresis. Since insufficient quantities of these proteins were available for vaccination trials, they were either sequenced 
directly from the N-terminus or subjected to endoproteinase Lys-C digestion, followed by peptide purification and amino acid 
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sequencing. This gave the information necessary for the expression of several of these proteins as recombinants in a form 
suitable for vaccination studies. 
Key words: Chrysomya bezziana, peritrophic membrane, vaccination, amino acid sequence, serine protease  
INTRODUCTION 
Successful vaccination against an ectoparasite 
would be an attractive alternative to pesticide usage. 
This approach to parasite control has been shown to be 
a promising alternative in controlling myiases flies and 
other ectoparasites (WILLADSEN et al., 1989; KAY and 
KEMP, 1994; TELLAM and BOWLES, 1997). Central to 
the development of a vaccine is the ability to isolate and 
identify protective antigens from the parasite. This task 
is often a multi-faceted and lengthy procedure. Firstly, a 
complex mixture of proteins, derived from either the 
whole organism or selected tissues, must be 
fractionated. Secondly, the isolated fractions must then 
be evaluated for protective efficacy in vaccination and 
parasite challenge experiments. The isolation and 
purification of just one protective antigen can take 
many fractionation steps and a number of vaccination 
trials before the efficacious protein is identified. 
Furthermore, antigen purification can be even more 
challenging, when the target proteins (eg. peritrophic 
membrane proteins) are membrane bound, often heavily 
glycosylated, and soluble only in surfactants and strong 
denaturants. The complexity and time-consuming 
nature of antigen identification is well illustrated in the 
development of a vaccine against the cattle tick, B. 
microplus (WILLADSEN et al., 1988; 1989) and the 
investigation of vaccination against the sheep blowfly, 
L. cuprina (EAST et al., 1993; ELVIN et al, 1996). 
The identification of protective antigens can be 
enhanced if the process begins, not with whole and 
therefore very complex parasite extracts, but with 
selected tissues or extracts. Two such sources of 
antigens have been extensively investigated with L. 
cuprina, the peritrophic membrane (PM) and the 
excretory/secretory (E/S) material (EAST et al., 1993; 
ELVIN et al., 1996; TELLAM and BOWLES, 1997). To 
date, the use of PM proteins as candidate vaccine 
antigens in other parasites has been somewhat limited, 
whereas proteases have been studied more 
comprehensively. For example, several antigens from 
E/S material of F. hepatica (liver fluke) have been 
reviewed (SPITHILL and DALTON, 1998). Vaccination 
with purified cysteine proteases (cathepsin L1 and L2) of 
F. hepatica decreases worm fecundity and provides 38 
– 69% protection (WIJFFELS et al., 1994, DALTON et al., 
1996). Serine proteases, as major proteolytic enzymes 
in insects, have been reviewed (APPLEBAUM, 1985; 
TERRA and FERREIRA, 1994; TERRA et al., 1996). These 
enzymes are thought to have an important role in 
wound formation and also to provide digestion of 
nutrients for L. cuprina larvae (SANDEMAN et al., 
1990).  Their use as possible vaccine antigens has been 
discussed (TELLAM and BOWLES, 1997). An in vitro 
feeding assay using several serine protease inhibitors 
caused the inhibition of larval growth and larval death 
(BOWLES et al., 1990; CASU et al., 1994), though 
vaccination with several enzymes individually has been 
unsuccessful (TELLAM et al., 1994). 
While L. cuprina larvae cause a cutaneous myaisis, 
C. bezziana larvae penetrate deeply into host muscle 
tissue. In view of the more invasive tissue penetration 
of C. bezziana larvae, the role of C. bezziana proteases 
might be more significant than those of L. cuprina. A 
preliminary biochemical investigation of E/S material 
of C. bezziana larvae has been performed (MUHARSINI 
et al., 2000). This material contains serine proteases as 
a major protein component. Both trypsin- and 
chymotrypsin-like enzymes are present. The C. 
bezziana serine proteases showed typical characteristics 
of insect proteases. However, their efficacy as an 
experimental vaccine in C. bezziana has not been 
described previously. 
In this paper, following the evidence that native C. 
bezziana PM material does induce a significant 
protective immune response against the parasite 
(SUKARSIH et al., 2000a), fractionation of this tissue has 
been performed and the protein components tested for 
vaccination efficacy. Results of the vaccination of sheep 
with C. bezziana protein extracts are presented. The 
purification and partial characterisation of some 
individual PM proteins from these extracts is also 
included. In addition, we describe the purification of 
several C. bezziana proteases from the larval E/S 
material and present the results of vaccination of these 
proteins in sheep. 
MATERIALS AND METHODS 
Production and harvest of larval peritrophic 
membrane and excretory/secretory material 
The establishment and maintenance of C. bezziana 
in laboratory culture is described in detail by SUKARSIH 
et al. (2000b). The procedures for growing C. bezziana 
in sterile larval culture, the harvesting of larval PM and 
the collection of larval E/S is similar to that described 
for L. cuprina (EAST et al., 1993) with some minor 
modifications for C. bezziana described by MUHARSINI 
et al. (2000). Following production, both the larval PM 
and E/S material were stored at –70oC until required. 
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Fractionation of peritrophic membrane proteins 
The extraction of proteins from C. bezziana PM was 
achieved by progressive homogenisation and treatment 
of the PM with various surfactants and chaotrophic 
agents of increasing solublization capacity, as 
previously described for the extraction of proteins from 
the PM of L. cuprina (EAST et al., 1993; ELVIN et al., 
1996). Some modifications of the L. cuprina protocol 
were developed over time with at least six batches (7.6 
g to 16.9 g wet wt.) of C. bezziana PM being processed 
during the course of the project. Typically, proteins 
were extracted sequentially from PM by 
homogenisation and incubation in the presence of 40 ml 
(final volume) of the following solutions: (1) water, (2) 
100 mM Tris-HCl, pH 7.2 containing 140 mM NaCl, 4 
mM EDTA, 50 µM 4-(2-aminoethyl)-benzenesulfonyl 
fluoride hydrochlorine (AEBSF) and Complete 
Protease Inhibitor (used according to the manufacturer’s 
instructions), (3) 20 mM Tris-HCl, pH 7.2, 140 mM 
NaCl, 4 mM EDTA, 50 µM AEBSF and Complete 
Protease Inhibitor (TBS+++) containing 2% SB 3-14 (N-
tetradecyl-N,N-dimethyl-3-ammonio-1-propane sulpho-
nate), (4) TBS+++ containing 6 M urea, and (5) TBS+++ 
containing 6 M guanidine-HCl. Following each 
extraction, homogenates were subject to centrifugation 
(48,000 g, 30 min, 4oC) followed by resuspension of the 
pellet in the next extraction solution. Extract incubation 
times were: water, 5 min; TBS, 30 min; 2% SB 3-14, 2 
h; 6 M urea, 16 h; and 6 M guanidine-HCl, 16 h. All 
extractions were performed at 4oC. All buffers, 
extraction solutions, media etc. mentioned in this paper 
were made using MilliQ water (MQW). 
To produce the sodium dodecyl sulfate (SDS) 
soluble fraction, the guanidine-HCl insoluble pellet was 
first washed twice with MQW followed by two washes 
with 50 mM Tris-HCl, pH 7.5. Following each wash the 
suspension was pelleted by centrifugation (14,000 g, for 
10 min at room temperature (RT) and the pellet 
resuspended in fresh buffer. The pellet was finally 
resuspended in 50 mM Tris-HCl, pH 7.5 containing 10 
mM dithiothreitol (DTT) and 5% SDS. The suspension 
was incubated for 30 min at 95oC, followed by 
centrifugation (14,000 g, 15 min at RT) and the SDS 
soluble supernatant was collected (SDS soluble 
material). 
Individual proteins present in various fractions that 
were chosen for further purification and 
characterisation, were named C. bezziana peritrophins 
followed by their apparent molecular weight (MW) on 
SDS-PAGE (eg. Cb-peritrophin 15, for convenience 
Cb15). 
 
 
 
Anion exchange high performance liquid 
chromatography 
Anion exchange high performance liquid 
chromatography (AE-HPLC) was used to further purify 
proteins present in the complex mixture of proteins 
isolated in the urea and guanidine-HCl soluble 
fractions. The AE-HPLC was performed on a Waters 
650E Advanced Protein Purification System using a 
Brownlee AX-300 anion exchange column (Applied 
Biosystems). Proteins were loaded onto the column in 
20 mM Tris-HCl buffer pH 8.4 containing 6 M urea, 
and eluted in a 0 to 1.0 M NaCl gradient in the same 
buffer. Cb68 was further purified on the same column 
and buffer system with 6M urea being replaced with 
0.1% SB 3-14. 
Purification of serine proteases from 
excretory/secretory material 
The purification of serine proteases from the E/S 
material of C. bezziana larvae was performed as 
previously described (MUHARSINI et al., 2000). Briefly, 
the serine proteases were purified using soybean trypsin 
inhibitor-Sepharose (SBTI-Sepharose) affinity 
chromatography. The proteins bound were eluted using 
100 mM acetic acid (pH 2.5) containing 0.1% SB 3-14 
(Boehringer). Fractions containing high protein 
concentrations were pooled for vaccination. 
SDS-PAGE 
Analytical gel electrophoresis of PM extracts and 
preparative gels for blotting and N-terminal sequencing 
were routinely conducted on 6-18% gradient SDS-
PAGE gels using the discontinuous buffer system 
described by LAEMMLI (1970). The in situ 
endoproteinase digestion of individual proteins was 
conducted on either 10 or 12% SDS-PAGE gels, 
depending on the MW of the target protein. Silver 
staining of gels was performed using the modified 
method of RABILLOUD et al. (1988). The apparent MW 
of target proteins was determined by a linear regression 
plot of the log10 MW verses relative electrophoretic 
mobility. 
Protein estimations 
Protein concentrations were estimated using BCA 
protein assay reagent (Pierce) and/or dye-binding 
protein assay reagent (Bio-Rad) (both used according to 
the  manufacturer’s   instructions).  Where   amounts  of  
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protein were too low or in short supply, a semi-
quantitative estimate was obtained by a comparison of 
selected stained protein bands on SDS-PAGE gels and 
MW standards of a known amount, run on the same gel. 
Purification of proteins for in situ digestion on SDS-
PAGE 
Four PM proteins were identified for processing. 
Individual aliquots of (1) SDS soluble material 
(containing approximately 400 µg of Cb15), (2) AE-
HPLC purified guanidine-HCl soluble fraction 
(containing approximately 75 µg of Cb23 and 150 µg of 
Cb42) and (3) AE-HPLC purified urea soluble fraction 
(containing approximately 100 µg of Cb68) were first 
precipitated with methanol (1:10) and incubated at –
20oC overnight. Following centrifugation (3000 g, 30 
min, 4oC) the pellet was resuspended in sample buffer 
containing 100 mM Tris-HCl pH 6.8, 10 mM DTT, 4% 
SDS, 10% glycerol and bromophenol blue. The protein 
samples were resolved by SDS-PAGE on a 12% 
analytical gel (Mini-PROTEAN II Electrophoresis 
System, Bio-Rad) at 200 V for 40 min and visualised 
with Coomassie Brilliant Blue R-250 stain (Biorad). 
In situ endoproteinase digestion of PM proteins and 
the isolation of peptides 
Protein bands corresponding to Cb15, Cb23, Cb42 
and Cb68 were excised from SDS-PAGE gels and cut 
into 1 mm2 pieces. Gel pieces were washed twice for 30 
min at RT in a solution containing 0.2 M ammonium 
bicarbonate and 50% acetonitrile (HPLC grade) and 
then dried under vacuum for 4 h. The desiccated gel 
pieces were rehydrated in 200 µl of digestion buffer 
containing 0.2 M ammonium bicarbonate, 1 mM EDTA 
and 5 µg of endoproteinase Lys-C (Boehringer 
Mannheim). On rehydration, gel pieces were sonicated 
for 5 min followed by incubation at 37oC for 16 h.  
Following enzymatic digestion, gel pieces were pelleted 
by centrifugation (14,000 g, 10 min, RT) and the 
supernatant containing cleaved peptides was collected. 
Gel pieces were washed with 200 µl of 1.0% 
trifluoroacetic acid (TFA) in MQW, sonicated for 30 
min at RT and centrifuged as before and the supernatant 
removed. A second wash contained 0.1% TFA and 60% 
acetonitrile. All supernatants were combined and the 
acetonitrile removed under vacuum. Peptides contained 
in the supernatant were isolated by reverse phase HPLC 
on a Brownlee RP-300 C-8 column. Sequential 
chromatographic separations of the peptides were 
performed, first in a 0.1% heptafluorobutyric acid-
acetonitrile gradient, then selected groups of peptides 
rechromatographed on a 0.1% TFA-acetonitrile gradient 
(WILLADSEN et al., 1989). Peptide sequencing was 
performed on an Applied Biosystems 471A protein 
sequencer. 
N-terminal sequencing 
Two independent preparations of Cb15 were 
sequenced, one containing approximately 100 pmol and 
the other, 500 pmol of protein (the second preparation 
was identical to that used for the generation of internal 
peptides described above). An aliquot of TBS extract 
containing approximately 200 pmol of Cb22 and 300 
pmol of Cb27 was also processed. Fractions were first 
separated by SDS-PAGE on 6 to 18% gradient gels. 
The proteins were then transferred to polyvinylidene 
difluoride (PDVF) membrane on a LKB Instruments 
Multiphor II Novablot semidry system according to the 
manufacturer’s instructions, using a transfer buffer 
containing 25 mM ethanolamine, 40 mM glycine and 
0.2% SDS. The PVDF membranes were stained in a 
solution containing 0.05% coomassie stain, 40% 
methanol, 1% acetic acid and 59% water for 5 min and 
then destained in methanol/water (1:1) and finally 
washed with MQW then air dried. Protein bands were 
excised and sequenced using an Applied Biosystems 
Blott cartridge. 
Sheep vaccination 
The protocol used in C. bezziana PM vaccination 
trials has been described previously (SUKARSIH et al., 
2000b). Briefly, for each fraction, 6 ml of extract was 
homogenized with 14 ml of Montanide ISA 70 adjuvant 
(Seppic, Paris, France) in the presence of antibiotics, 
20.000 IU of penicillin and 25 mg of streptomycin. 
In the vaccination trial assessing PM fractions, 
merino sheep (six animals per group) were used and 
were vaccinated twice, four weeks apart. The amount of 
protein injected per sheep per vaccination was: water 
wash, 0.37 mg; TBS extract, 0.36 mg; SB 3-14, 1.09 
mg; urea extract, 0.45 mg; guanidine-HCl extract, 0.85 
mg and SDS soluble material, 1.65 mg. 
The vaccination trial for SBTI purified serine 
proteases was carried out using Javanese Thin Tail 
sheep (six animals per group). Animals were vaccinated 
three times. The second and third vaccinations were 
carried out four weeks and six weeks respectively, after 
the first vaccination. Each animal was injected with 40 
µg of purified serine proteases per vaccination. 
In vitro and in vivo larval assays 
The procedure used for C. bezziana in vitro larval 
assays was essentially that described for L. cuprina 
(EISEMANN et al., 1989) with some minor modifications 
(SUKARSIH et al., 2000a). The assay for each serum was 
carried out with five-fold replication and the larval 
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recoveries and weights averaged for each serum. The 
procedure used for C. bezziana in vivo larval assays has 
been described (PARTOUTOMO et al., 1998; SUKARSIH 
et al., 2000a) and was similar to that described for the 
measurement of growth and survival of L. cuprina on 
sheep (EISEMANN et al., 1989). The parameters of larval 
weight and larval recovery were compared between 
control and vaccinated groups. Statistical analyses of 
the in vitro assay data were performed using a student’s 
T-test. In vivo data was analysed using a two way 
ANOVA analysis of variance with treatment and site of 
infestation as factors. 
ELISA assays 
ELISA assays were performed as described by 
SUKARSIH et al. (2000a). Titres for the sheep vaccinated 
with PM fractions were standardized against a pool of 
antisera from sheep vaccinated with whole PM and 
assigned an arbitrary titre of 20,000, which lay within 
the linear portion of a calibration curve (SUKARSIH et 
al., 2000a). For the E/S proteases, the coating antigen 
was purified proteases (same as the vaccination 
antigen), at a concentration of 20 µg/ml. 
RESULTS 
Fractionation of PM proteins 
Vaccination of sheep with homogenised whole C. 
bezziana PM induced a significant immune response 
against the parasite (SUKARSIH et al., 2000a). In vitro 
assay results showed a reduction in larval weights of 
73% and a reduction in the number of larvae recovered 
of 32% giving an overall reduction in the mass of larvae 
recovered of 82%. In vivo results showed a 41% 
reduction in larval weights and 13% reduction in larval 
recovery giving an overall reduction in the mass of 
larvae recovered of 49%. These results provided strong 
evidence that components of PM can induce a 
significant protective response and justified the 
fractionation and purification of PM components with 
the intention of identifying and characterizing the 
antigens responsible for protection. 
The cultured PM was fractionated in batches 
ranging from between 7.6 g and 16.9 g (wet wt.). In 
early fractionations, the amount of extraneous material 
co-pelleting with the PM on harvest was evident in the 
first water wash (preparation 2, Table 1). In later 
preparations, more attention was given to PM 
cleanliness, with larval growth medium, exudate and 
faecal contamination being thoroughly washed away 
from the PM prior to homogenisation (preparation 4, 
Table 1). The low proportion of total weight extractable 
as protein reflects, in part, the large amount of water 
entrapped in the PM but also the amount of material 
remaining insoluble in the residue of the PM even after 
very vigorous extraction. 
Table 1. Protein yield from four PM protein 
fractionations 
 Preparation 
 1 2 3 4 
PM (g wet wt.) 7.60 8.54 13.08 13.22 
Water wash (mg) 2.90 7.18 3.19 1.84 
TBS extract (mg) 1.18 1.02 1.18 3.65 
SB 3-14 extract (mg) 3.46 2.95 4.36 10.12 
Urea extract (mg)  2.44 2.03 1.22 4.78 
Guanidine-HCl 
extract (mg) 
2.90 2.18 3.89 7.52 
SDS soluble material 
(mg) 
   12.17 
A flow diagram showing the protein extracts 
removed from the whole PM following progressive 
treatment with agents of increasing solublisation 
capacity is presented in Figure 1. With each successive 
extraction step, different groups of proteins were 
dislodged from the PM membrane. The extracted 
proteins present in each fraction are visualised on the 
SDS-PAGE gradient gel shown in Figure 2. The 
amount of protein recovered at each extraction step 
from four independent preparations is shown in Table 1. 
The PM used in these extractions was stored wet prior 
to use and contained varying amounts of buffer, which 
is included in the wet weight shown in Table 1. 
Preparations 3 and 4 were used in the sheep vaccination 
trial, the results of which are presented below. 
 
Figure 1. Flow diagram of the sequential extraction of 
proteins from C. bezziana PM. The origins of 
specific major PM proteins that were 
subsequently purified and identified by amino 
acid sequencing are indicated 
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Figure2. Silver stained SDS-PAGE gels of proteins 
extracted from C. bezziana PM. The gel was 
run under reducing conditions (10 mM DTT). 
Low MW markers (Pharmacia) were run in 
lane 1. Two aliquots (30 µl and 10 µl) of each 
extract were run; PM water wash, lane 3 and 
4; TBS extract, lanes 6 and 7; SB 3-14 
extract, lanes 9 and 10; urea extract, lanes 11 
and 12; guanidine-HCl extract, lanes 14 and 
15 and the SDS soluble material, lanes 17 and 
18. Selected PM proteins that were 
subsequently characterised by N-terminal and 
internal amino acid sequencing are labelled. 
The asterisk indicates an unnamed major 
protein of approximately 40 kDa MW on 
which N-terminal sequencing was attempted 
but was unsuccessful 
Vaccination with PM fractions 
A vaccination trial was carried out in sheep and the 
vaccination efficacy determined with in vitro assays. 
The results are listed in Table 2. The effect of 
vaccination with the PM water wash, TBS extract and 
SB 3-14 extract were not statistically significant. The 
most effective fraction was the urea extract with a 
reduction in larval recovery of 11% (p=0.05) and a 
reduction in larval weight of 30% (p=<0.05). To a 
lesser extent the guanidine-HCl extract and the SDS 
soluble material gave some protection with a reduction 
in larval weight of 15% (p<0.05) and 19% (p<0.01) 
respectively. Reduction in larval recovery for the 
guanidine-HCl extract was 9% (p≤0.05) but was not 
significant with the SDS soluble material. 
ELISAs were conducted on the same sera as those 
used for in vitro assays. With the exception of the SB 3-
14 group, all vaccinated animals showed a good 
immune response. Antibody titres ranged from 32,000 
to greater than 250,000. In contrast, the titres of the SB 
3-14 vaccinates were 0-16,000. The absence of 
comparable high antibody titres in this group may have 
been due to the presence of the SB 3-14 detergent in the 
antigen preparation. We observed poor emulsion 
formation with the adjuvant in the presence of the 
detergent. However, in a repeat of the SB 3-14 
vaccination trial, the detergent was removed from the 
fraction by methanol precipitation prior to mixing with 
adjuvant. Even though a significant immune response 
was obtained, protection as measured by in vitro assay 
was still not significant (data not shown). 
Table 2. Vaccination with PM fractions: in vitro assays 
Fraction 
Reduction in 
larval recovery 
(%) 
Reduction in 
larval weight 
(%) 
Water wash N.S. 24 (N.S.) 
TBS extract N.S. N.S. 
SB 3-14 extract N.S. N.S. 
Urea extract 11 (p = 0.05) 30 (p<0.05) 
Guanidine-HCl 
extract 
9 (p<0.05) 15 (p<0.05) 
SDS soluble 
material 
N.S. 19 (p<0.01) 
N.S. = not significant 
Identification of major proteins extracted from PM 
The vaccination results with whole PM and with PM 
extracts, together with the suggested mechanism of 
vaccination effects in L. cuprina (WILLADSEN et al., 
1993) indicated it was appropriate to focus on the major 
proteins present in protective PM fractions. Some of the 
major proteins present in protective C. bezziana 
fractions (Figure 2) were selected for further 
purification and characterization by amino acid 
sequencing. Proteins nominated for further 
characterization included Cb22 and Cb27 from the TBS 
extract, Cb23 and Cb68 from the urea extract, Cb42 
from the guanidine-HCl extract and Cb15 from the SDS 
soluble material. The migration of these proteins on 6 to 
18% gradient SDS-PAGE gels are indicated in Figure 2. 
The apparent molecular weights of selected proteins, 
determined by a linear regression plot of the log10 MW 
verses relative electrophoretic mobility, are presented in 
Table 3. 
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Table 3. Apparent molecular weight of selected PM 
proteins 
PM protein Molecular weight (daltons) 
Cb15 15,300 
Cb22 20,900 
Cb27 25,700 
Cb42 41,000 
Cb68 70,000 
In situ endoproteinase Lys-C digestion of Cb15, 
Cb23, Cb42 and Cb68 proteins was successful (Table 
4). Cb68 peptide sequences are presented in Table 4. 
The N-terminal sequences of Cb15 (WIJFFELS et al., in 
preparation), Cb22, Cb27 and some other proteins 
sourced from anion exchange fractions (Table 4), were 
obtained after blotting directly from SDS-PAGE gels 
onto PVDF membrane. Cb22 and Cb27 had identical N-
terminal sequences and were identical to that of C. 
bezziana excreted/secreted serine proteases isolated 
from C. bezziana growth media (MUHARSINI et al., 
2000). The four proteases are probably very closely 
related proteins or in fact truly identical. Attempts to N-
terminally sequence Cb42 and Cb68 and the major 
protein (approximately 40 kDa) present in the urea 
extract (marked * in Figure 2) were unsuccessful and it 
was assumed they were N-terminally blocked. 
Chemical modification of protein N-termini can often 
occur during protein purification. 
Amino acid sequence information obtained from 
native Cb15 and Cb42 has been used to facilitate the 
identification of the genes encoding each protein 
(WIJFFELS et al., in preparation; MUHARSINI et al., in 
preparation). Attempts have been made to isolate the 
Cb68 gene, but without success. Cb23 peptides have 
near identical sequences to Cb15 and the protein species 
isolated from the urea fraction is assumed to be an 
aggregate of Cb15. 
Vaccination with excretory/secretory proteases 
Vaccination with affinity purified serine proteases 
were assessed with in vitro and in vivo assays. Table 5 
shows a 3% reduction on larval recovery and no 
increase on larval weight from the in vitro assays. 
Statistically, there was no significant difference 
between vaccinated and control animals for either of 
these parameters. In contrast, in vivo assays showed 
significant effects of vaccination on these parameters 
(Table 5). The in vivo results showed an average 
reduction in larval weight of 37% in the larvae returned 
from the vaccinated sheep. The results were analyzed in 
terms of two effects which potentially contributed to 
these differences: the effect of vaccination with C. 
bezziana larval serine proteases and the site of the larval 
infestation (ring position) which was replicated on each 
animal. The reduction in larval weights on vaccination 
was highly significant (F1,47 = 22, p<0.001). There was 
no effect of ring position. 
Table 4. Amino acid sequences of PM protein N-termini 
and endoproteinase Lys-C generated peptides 
Peptide Amino acid sequence 
N-terminal sequences 
Cb15 
Cb22 
Cb27  
SWAXU41 
SWAXU42 
SWAXU70 
 
(WIJFFELS et al., in preparation) 
IVGGVATTIGNFPWQVSLQR 
IVGGVATTIGNFPWQVSLQR 
NYGMEQA 
DEEAKKEEXGNK 
VXNKXQPNGV 
Cb15 Peptides 
Five peptides 
sequenced 
(WIJFFELS et al., in preparation) 
 
Cb23 Peptides 
Two peptides 
sequenced 
(WIJFFELS et al., in preparation) 
Cb42 Peptides 
Three peptides 
sequenced 
(MUHARSINI et al., in preparation) 
Cb68 Peptides 
SWAX68U03 
SWAX68U06 
SWAX68U94 
 
(K)NYIYMYRK 
(K)QTVAGRYPYPNDTXH 
(K)ANXGEYPN 
1 The one letter code for amino acids has been used. The initial (K) of 
a peptide sequence is assumed to be present because of the specificity 
of the endoproteinase Lys-C. Residues that could not be assigned with 
confidence are represented with an X. 
Interestingly, the average larval recovery increased 
21% for vaccinated animal as compared to the controls. 
This was significant (F1,47 = 10, p<0.05). As with the 
larval weights, ring position did not influence larval 
recovery. 
Table 5. Vaccination with serine proteases: in vitro and in vivo 
assays  
In vitro In vivo 
Antigen Larval 
recovery 
(%) 
Larval 
weight 
(mg) 
Larval 
recovery 
(%) 
Larval 
weight 
(mg) 
Serine 
protease 
81.3 ± 3.3 2.2 ± 0.3 72 17.3 
Control 84.3 ± 6.1 2.2 ± 0.4 60 27.5 
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DISCUSSION 
The results presented in this paper show that the 
isolation and characterisation of potential antigens, even 
those as difficult to study as membrane bound 
glycoproteins, is possible using a range of techniques 
which are potentially available to any protein 
biochemistry laboratory. In purifying proteins it is 
usually advantageous and frequently essential to 
develop initial separation steps which can be carried out 
on relatively large amounts of material but which 
nevertheless lead to a workable number of fractions 
containing discrete protein species. This is obviously 
possible with proteases extracted from excretory/ 
secretory material by affinity chromatography on SBTI-
Sepharose. However, it applies equally to the 
peritrophic membrane, where a series of sequential 
extraction procedures using surfactants and denaturants 
of increasing severity is able to separate discrete classes 
of proteins even from a difficult tissue like the 
peritrophic membrane. 
It is interesting to note that the N-terminal protein 
sequence obtained from some of the secretory/ 
excretory proteases (MUHARSINI et al., 2000) is 
identical to two of the proteins extracted from the 
peritrophic membrane in TBS. There are two possible 
explanations for this. The family of serine proteases 
shows regions of high sequence conservation. Using 
PCR primers designed around these regions, a large 
number of serine protease genes have been identified in 
L. cuprina (ELVIN et al., 1994). Using a statistical 
argument, this sequence information was used to further 
predict that the probable size of the family of serine 
proteases in this parasite was about 200 (ELVIN et al., 
1994). Therefore, it may not be surprising if an identical 
N-terminal sequence is obtained for a number of these 
proteases, with varying molecular weight and fraction 
origin. Certainly, it is reasonable to expect serine 
proteases in both the secretory/excretory material and in 
the peritrophic membrane, that is, involved in protein 
digestion in the wound and in the parasite's digestive 
system. The second explanation appears, at first sight, 
less likely, namely that the same enzymes could be both 
membrane bound then secreted. However this has been 
shown to be the case with another protein from a 
pertirophic membrane, PM 95 from L. cuprina 
(TELLAM et al., 2000). 
The two vaccine assay systems used in this work 
again are likely to measure different components of the 
host-parasite interaction. The in vitro assay system uses 
serum from vaccinated animals in an agar medium. As 
such, factors controlling wound formation are unlikely 
to be important, but those affecting digestion relatively 
important. By contrast, the in vivo assay system, since it 
involves penetration of first instar larvae into a minimal 
wound in sheep skin, would clearly be dependent on the 
efficacy of wound formation as well as on subsequent 
feeding performance. The use of these two assay 
systems jointly can begin to give some information 
about the relevance of the target antigens to these two 
processes. 
It is therefore interesting that vaccination of sheep 
with serine proteases followed by in vitro feeding 
showed no significant effect of the serum. The very 
marginal effects on larval weight were not statistically 
significant and very much less than the dramatic effects 
on larval weight in the same feeding system shown after 
feeding larvae on serum from sheep vaccinated with 
larval peritrophic membrane. In contrast, effects in vivo 
showed a significant reduction in larval weight after a 
standardised feeding interval. 
There are two obvious possible explanations for this 
observation. The first is that the proteases used in 
vaccination are important in wound formation and 
establishment and feeding of larvae in sheep, but not 
critical in the artificial system of the in vitro feeding. 
The second is that some component of the immune 
system is present in the in vivo feeding but absent or in 
reduced quantities in the in vitro system. This second 
possibility can certainly not be excluded. For example, 
even the availability of complement will be much less 
after preparation of the in vitro feeding medium. 
The observation that there is a slight though 
statistically significant increase in larval recovery after 
in vivo feeding on sheep vaccinated with proteinases is 
surprising. Nevertheless, there is also evidence from 
vaccination with peritrophic membrane as well as 
vaccination with some recombinant peritrophic 
membrane proteins, that the production of antibody to 
these leads not to inhibition of feeding, but to some 
significant increases in the recovery of larvae in vivo in 
the absence of any detectable effect in vitro. One 
possible explanation of this is that formation of antigen-
antibody complexes in the developing wound may, by 
causing localised inflammation, facilitate larval feeding. 
This, if true, complicates the interpretation of 
vaccination effects but is also an important 
consideration in vaccine development. 
In addition to the serine proteases, C. bezziana E/S 
material contains a number of gelatin-degrading 
enzymes not inhibited by the classic serine protease 
inhibitors (MUHARSINI et al., 2000). These too are 
potential vaccine antigens, but their efficacy remains to 
be investigated. 
For the peritrophic membrane, the results in this 
paper extend the observations with whole peritrophic 
membrane reported elsewhere (SUKARSIH et al., 2000a). 
Several fractions have significant effects in vitro, 
though the effects are markedly less than that of the 
whole membrane. It has also been shown that these 
proteins once separated on SDS-PAGE can yield both 
N-terminal and internal amino acid sequences. These 
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can be obtained working with amounts of proteins in 
the low µg range. As will be described in subsequent 
papers (this issue), such peptide sequence is usually 
essential for the identification of the gene coding for the 
protein of interest. 
CONCLUSIONS 
Fractions derived from the peritrophic membrane 
and affinity purified serine proteases are both able to 
induce immune responses in vaccinated sheep which 
confer a degree of immune protection against larval 
screwworm fly. Techniques exist for the 
characterization of individual antigens in these 
relatively simple antigenic mixtures in terms of unique 
amino acid sequences, obtained on amounts of antigen 
in the low microgram range. This characterization, in 
turn, permits the expression of such antigens as 
recombinant proteins. These are key steps in the 
investigation of the true feasibility of vaccine 
development. 
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